Minerva Surgical, Inc. (NASDAQ:UTRS) Q2 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Minerva Surgical Q2 2023 Earnings Call. At this time all participants are in listen-only mode.
Stay updated with breaking news from Todd Usen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Greetings, and welcome to the Minerva Surgical Q2 2023 Earnings Call. At this time all participants are in listen-only mode.
Operator: Thank you for standing by, and welcome to Minerva's Fourth Quarter and Full Year 2022 Earnings Call. At this time, all participants are in a listen-only mode.
Women's health company Minerva Surgical (Nasdaq:UTRS) announced that it appointed Kaile Zagger as its new chief commercial officer.
Minerva Surgical (Nasdaq:UTRS) announced today that it closed a sale of common stock in a private placement worth approximately $30 million.
09.02.2023 - SANTA CLARA, Calif., Feb. 09, 2023 (GLOBE NEWSWIRE) - Minerva Surgical, Inc. (Nasdaq: UTRS) (Minerva Surgical or the Company), a women’s health company focused on the treatment of Abnormal Uterine Bleeding (AUB), announced today that it has closed ... Seite 1